Brief: China NT Pharma Group Co says HY profit attributable to equity shareholders up 61.1 pct
21/08/2017 14:56
Aug 21 (Reuters) - China NT Pharma Group Co Ltd 1011.HK :
* HY profit attributable to equity shareholders of company
increased by 61.1% from RMB50.1 million to RMB80.7 million
* HY overall revenue of group up 44.9 percent to RMB559.1
million
Source text for Eikon: ID:nHKS36BBry
Further company coverage: 1011.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million